CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the effectiveness of combining radiation therapy with lomustine chemotherapy for patients with recurrent glioblastoma. It aims to establish a new standard of care that could improve patient survival and quality of life while considering health system sustainability.
Recurrent glioblastoma is an invariably fatal refractory cancer with dismal prognosis.
Patients suffer from low quality of life and very burdensome symptoms.
This project is proposing an investigator-initiated phase III randomised pragmatic clinical trial.
We will assess whether the addition of radiation treatment to lomustine chemotherapy has superior efficacy as compared to lomustine chemotherapy alone for treatment of patients with recurrent glioblastoma.
The study will apply minimal patient…
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Italy, Roma
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
